Active Substance: fluticasone furoate Common Name: fluticasone
furoate ATC Code: R01AD12 Marketing Authorisation Holder: Glaxo
Group Limited Active Substance: fluticasone furoate Status:
Authorised Authorisation Date: 2008-01-11 Therapeutic Area:
Rhinitis, Allergic, Seasonal Rhinitis, Allergic, Perennial
Pharmacotherapeutic Group: Nasal preparations, corticosteroids
Therapeutic Indication  Adults, adolescents (12 years and over)
and children (6-11 years). Avamys is indicated for the treatment
of the symptoms of allergic rhinitis.  What is Avamys?  Avamys
is a nasal spray that contains the active substance fluticasone
furoate.  What is Avamys used for?  Avamys is used to treat the
symptoms of allergic rhinitis. This is inflammation of the nasal
passages caused by an allergy, resulting in runny nose, blocked
nose, itching and sneezing. It is often accompanied by symptoms
affecting the eyes, such as irritation, watering or redness.
Avamys is for use in patients aged six years and over.  The
medicine can only be